Page last updated: 2024-09-03

3-carboxy-4-methyl-5-propyl-2-furanpropionic acid and phenylbutazone

3-carboxy-4-methyl-5-propyl-2-furanpropionic acid has been researched along with phenylbutazone in 1 studies

Compound Research Comparison

Studies
(3-carboxy-4-methyl-5-propyl-2-furanpropionic acid)
Trials
(3-carboxy-4-methyl-5-propyl-2-furanpropionic acid)
Recent Studies (post-2010)
(3-carboxy-4-methyl-5-propyl-2-furanpropionic acid)
Studies
(phenylbutazone)
Trials
(phenylbutazone)
Recent Studies (post-2010) (phenylbutazone)
1006386,291317125

Protein Interaction Comparison

ProteinTaxonomy3-carboxy-4-methyl-5-propyl-2-furanpropionic acid (IC50)phenylbutazone (IC50)
fMet-Leu-Phe receptorHomo sapiens (human)5.3
Cyclooxygenase-2 Canis lupus familiaris (dog)3.79

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goto, M; Maruyama, T; Matsunaga, H; Otagiri, M; Takadate, A; Tsutsumi, Y1

Other Studies

1 other study(ies) available for 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid and phenylbutazone

ArticleYear
Interaction between two dicarboxylate endogenous substances, bilirubin and an uremic toxin, 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, on human serum albumin.
    Pharmaceutical research, 1999, Volume: 16, Issue:6

    Topics: Bilirubin; Binding Sites; Binding, Competitive; Dicarboxylic Acids; Furans; Humans; Hydrogen-Ion Concentration; Ligands; Phenylbutazone; Propionates; Protein Conformation; Serum Albumin; Warfarin

1999